Prognostic significance of microRNA-16 expression in human colorectal cancer

World Journal of Surgery

Volumn 37, Issue 12, 2013, Pages 2944-2949

  Qian, Jun ^a   Jiang, Bin ^a   Li, Min ^a   Chen, Juan ^a   Fang, Mingzhi ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN16 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; COHORT ANALYSIS; COLON; COLORECTAL TUMOR; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLON; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84890435747     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2205-4     Document Type: Article

References (25)

1. Center MM, Jemal A, Smith RA et al (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366-378
2. Bolocan A, Ion D, Ciocan DN et al (2012) Prognostic and predictive factors in colorectal cancer. Chirurgia (Bucur) 107:555-563
3. Ke XS, Liu CM, Liu DP et al (2003) MicroRNAs: key participants in gene regulatory networks. Curr Opin Chem Biol 7:516-523
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
5. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6:590-610
6. Shen J, Stass SA, Jiang F (2013) MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 329:125-136
7. Garzon R, Marcucci G (2012) Potential of microRNAs for cancer diagnostics, prognostication and therapy. Curr Opin Oncol 24:655-659
8. Takeshita F, Patrawala L, Osaki M (2010) Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18:181-187
9. Agra Andrieu N, Motiño O, Mayoral R (2012) Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells. PLoS One 7:e50935
10. Ma Q, Wang X, Li Z et al (2013) microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway. Oncol Rep 29:1652-1658
11. Bendardaf R, Lamlum H, Pyrhönen S (2004) Prognostic and predictive molecular markers in colorectal carcinoma. Anticancer Res 24:2519-2530
12. Pasche B, Mulcahy M, Benson AB 3rd (2002) Molecular markers in prognosis of colorectal cancer and prediction of response to treatment. Best Pract Res Clin Gastroenterol 16:331-345
13. Schetter AJ, Okayama H, Harris CC (2012) The role of microRNAs in colorectal cancer. Cancer J 18:244-252
14. Corté H, Manceau G, Blons H et al (2012) MicroRNA and colorectal cancer. Dig Liver Dis 44:195-200
15. Weiland M, Gao XH, Zhou L et al (2012) Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 9:850-859
16. Zhou L, Zhao YP, Liu WJ et al (2012) Circulating microRNAs in cancer: diagnostic and prognostic significance. Expert Rev Anticancer Ther 12:283-288
17. Li J, Du L, Yang Y et al (2013) MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett 329:84-90
18. Nishimura J, Handa R, Yamamoto H et al (2012) MicroRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep 28:2221-2226
19. Wang Q, Huang Z, Ni S et al (2012) Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 7:e44398
20. Pichler M, Winter E, Stotz M et al (2012) Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer. Br J Cancer 106:1826-1832
21. Xi Y, Li J, Zan L et al (2013) Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia. Hum Pathol 44:1011-1016
22. Navarro A, Diaz T, Gallardo E et al (2011) Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol 103:411-415
23. Gao X, Zhang R, Qu X et al (2012) MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma. Leuk Res 36:1505-1509
24. Wu H, Liu T, Wang R et al (2011) MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2. IUBMB Life 63:101-108
25. McShane LM, Altman DG, Sauerbrei W et al (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer 41:1690-1696